Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILDAGLIPTIN vs VINORELBINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VILDAGLIPTIN vs VINORELBINE: Safety Overview

Metric VILDAGLIPTIN VINORELBINE
Total FAERS Reports 2,063 5,176
Deaths Reported 181 840
Death Rate 8.8% 16.2%
Hospitalizations 1,064 1,790
Average Patient Age 70.8 yrs 54.8 yrs
% Female Patients 49.6% 71.8%
FDA Approval Date N/A Apr 18, 2005
Manufacturer N/A Sagent Pharmaceuticals
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued